Zotepine for Behavioural and Psychological Symptoms in Dementia: An Open-Label Study

By Michael K. Rainer  

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1165-1165

Adis International

Access to resources Recommend Favorite

Zotepine for Behavioural and Psychological Symptoms in Dementia: An Open-Label Study

By Rainer M.K.  

CNS Drugs, Vol. 18, Iss. 1, 2004-01 ,pp. : 49-55

Adis International

Access to resources Recommend Favorite

Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson's Disease Dementia: A Retrospective Analysis of a Double-Blind Trial and an Open-Label Extension

By Oertel Wolfgang  

Drug Safety, Vol. 31, Iss. 1, 2008-01 ,pp. : 79-94

Adis International

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study

By Shua-Haim Joshua  

Clinical Drug Investigation, Vol. 28, Iss. 6, 2008-01 ,pp. : 361-374

Adis International

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite